Princeton Alpha Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-9,013
Closed -$758K 206
2017
Q1
$758K Sell
9,013
-23,496
-72% -$1.88M 0.25% 113
2016
Q4
$2.39M Buy
32,509
+28,999
+826% +$2.16M 0.49% 25
2016
Q3
$282K Sell
3,510
-3,635
-51% -$291K 0.05% 519
2016
Q2
$563K Sell
7,145
-12,332
-63% -$928K 0.1% 316
2016
Q1
$1.4M Buy
19,477
+14,110
+263% +$1.07M 0.23% 132
2015
Q4
$452K Buy
+5,367
New +$445K 0.08% 371
2015
Q3
Sell
-29,176
Closed -$2.44M 828
2015
Q2
$2.44M Buy
29,176
+13,609
+87% +$1.04M 0.48% 32
2015
Q1
$1.13M Buy
15,567
+7,877
+102% +$561K 0.24% 115
2014
Q4
$531K Sell
7,690
-19,117
-71% -$1.29M 0.15% 208
2014
Q3
$1.74M Buy
+26,807
New +$1.7M 0.39% 47

Other funds holding LLY

Princeton Alpha Management's LLY Position: Q2 2017 in Review

Princeton Alpha Management sold out of Eli Lilly (LLY) in Q2 2017, closing a stake of 9,013 shares — an estimated $758K sold.

Princeton Alpha Management first reported a position in LLY in Q3 2014 and held it in 10 quarters. The position peaked at $2.44M in Q2 2015. 1,246 funds tracked by Wall St. Rank hold LLY as of Q2 2017.

  • Princeton Alpha Management reported no remaining Eli Lilly position as of Q2 2017 after selling out during the quarter.
  • Princeton Alpha Management sold 9,013 Eli Lilly shares in Q2 2017, an estimated $758K.
  • Princeton Alpha Management first reported a position in Eli Lilly in Q3 2014 and held it in 10 quarters.
  • Princeton Alpha Management's Eli Lilly position peaked at $2.44M in Q2 2015.
  • 1,246 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.

Based on Princeton Alpha Management's 13F filing for Q2 2017.